IP Verse

Argentum Pharmaceuticals competitive analysis

Latest PTAB cases involving Argentum Pharmaceuticals

Discover the latest PTAB cases involving Argentum Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 1, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Argentum Pharmaceuticals

IPR2018-00423Jan 5, 2018ARGENTUM PHARMACEUTICALSMERCK PATENTGESELLSCHAFT MIT BESCHRANKTER HAFTUNGInstitution Denied
IPR2018-00080Oct 20, 2017ARGENTUM PHARMACEUTICALSCOSMOTerminated-Settled
IPR2017-01762Jul 12, 2017ARGENTUM PHARMACEUTICALSICOSTerminated-Settled
IPR2017-01550Jun 9, 2017ARGENTUM PHARMACEUTICALSNOVARTISFinal Written Decision
IPR2017-01429May 12, 2017ARGENTUM PHARMACEUTICALSKAKEN PHARMACEUTICALTerminated-Settled
IPR2017-01053Mar 10, 2017ARGENTUM PHARMACEUTICALSALCON RESEARCHFinal Written Decision
IPR2017-01063Mar 10, 2017ARGENTUM PHARMACEUTICALSNOVARTISFinal Written Decision
IPR2017-00807Feb 2, 2017ARGENTUM PHARMACEUTICALSCIPLATerminated-Settled
IPR2016-01317Jun 29, 2016ARGENTUM PHARMACEUTICALSJANSSEN ONCOLOGYFinal Written Decision
IPR2016-01232Jun 22, 2016ARGENTUM PHARMACEUTICALSALLERGANTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Argentum Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ARGENTUM PHARMACEUTICALS - - 12 -
ALCON RESEARCH - 1418
CIPLA1166
NOVARTIS6424 - 21